Growing new organs starts with building something that looks like an embryo
To one day grow new organs, or even entire bodies, scientists first need to understand how an embryo pulls it off. The latest step: so-called pseudo-embryos that lay down multiple organs at the same time.
It sounds like science fiction, but it is a serious line of inquiry in regenerative medicine: growing new organs for people who have lost their own to disease or old age. No waiting for a donor, no living with rejection problems from a foreign organ, just producing a fresh replacement from your own cells. That the principle works has already been demonstrated for simple structures such as skin tissue. The challenge is scaling it up to complex organs with dozens of cell types, blood vessels, nerves, and a precise spatial organisation.
The latest strategy goes a step beyond growing isolated organ-like structures, known as organoids. Researchers are working on what they call multi-organ pseudo-embryos: synthetic structures that, much like an early embryo, lay down multiple organs simultaneously in the correct spatial relationship to one another. The idea is that nature has already solved this problem; in an embryo, a cluster of cells organises itself within days into a complete body plan. If you can understand the signals that drive that process, you may be able to recreate it outside the body.
Why organoids are not enough
Organoids, miniature organ-like structures that grow in a petri dish, are one of the great success stories of biotechnology over the past two decades. You can use them to produce heart tissue, intestinal tissue, even primitive brain structures. But they are missing something essential: architecture. A real organ is not just made up of the right cells; it also depends on the right structure, blood vessels that branch in exactly the right way, connective tissue that forms organ walls, nerve fibres that make the correct connections. Organoids do not have that structure.
Pseudo-embryos are an attempt to reproduce that architecture as well, by studying how early embryonic cells arrange themselves. This is not about growing real human embryos for medical purposes, which raises ethical questions that put it out of reach for now. Pseudo-embryos are synthetic constructs, built from stem cells, that mimic a handful of early developmental stages.
How far has the science actually come?
It is important to stay clear-eyed here. The gap between a pseudo-embryo in a laboratory and a fully functional grown organ that can be implanted in a human being is enormous. The tools are still crude, and our understanding of how cell biochemistry fits together at the molecular level is incomplete. But the direction is clear: whoever can control cell behaviour can ultimately produce tissues and organs on demand. Whether that will ever be possible no longer seems to be the question; it is a matter of when.